Cargando…

Editorial: Cardiovascular Diseases Related to Diabetes and Obesity

Detalles Bibliográficos
Autores principales:	Rajesh, Mohanraj, Xin, Ying, Young, Jamie L., Cai, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169566/ https://www.ncbi.nlm.nih.gov/pubmed/35677720 http://dx.doi.org/10.3389/fendo.2022.916142

Ejemplares similares

Editorial: Cardiovascular diseases related to diabetes and obesity – volume II
por: Young, Jamie L., et al.
Publicado: (2022)

Editorial: Cardiovascular Disease and Diabetes
por: Santulli, Gaetano
Publicado: (2019)

Editorial: The Role of Ceramides in Diabetes and Cardiovascular Disease
por: Summers, Scott A.
Publicado: (2021)

Editorial: Non-coding RNA in diabetes and cardiovascular diseases
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

Editorial: Advanced Cardiovascular Imaging in Diabetes
por: Schick, Fritz, et al.
Publicado: (2022)

Editorial: Diabetes and Obesity Effects on Lung Function
por: Chen, Xiao-Feng, et al.
Publicado: (2020)

Editorial: Endocrine-related cardiovascular diseases: Recent advances in diagnosis and treatment
por: Bhat, Audesh, et al.
Publicado: (2023)

Editorial: Insulin resistance and cardiovascular disease
por: Stewart, Alan J., et al.
Publicado: (2023)

Editorial: Connecting the Dots Between Obesity, Diabetes and Cancer
por: Tong, Xuemei, et al.
Publicado: (2020)

Editorial: Research Topic for Frontiers in Endocrinology (Obesity): Fetal Origin of Obesity and Diabetes
por: Sliwowska, Joanna H., et al.
Publicado: (2022)

Editorial: The link between obesity, type 2 diabetes, and mitochondria
por: Luo, Moulun, et al.
Publicado: (2023)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022)

Editorial: Obesity and Diabetes: Energy Regulation by Free Fatty Acid Receptors
por: Ichimura, Atsuhiko, et al.
Publicado: (2015)

Editorial: Pharmacological and non-pharmacological therapy for obesity and diabetes - volume II
por: Oliveira, Alexandre Gabarra, et al.
Publicado: (2023)

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease
por: Di Pietro, Paola, et al.
Publicado: (2023)

History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women
por: Shostrom, Derrick C. V., et al.
Publicado: (2017)

Editorial: Hypothalamic obesity: Today and future
por: van Santen, H.M., et al.
Publicado: (2022)

Editorial: The Impact of Adipose Tissue Dysfunction on Cardiovascular and Renal Disease
por: Sun, Xiaodong, et al.
Publicado: (2022)

Editorial: The effects of circulating non-sex hormones in cardiovascular disease
por: Shan, Su-Kang, et al.
Publicado: (2022)

Editorial: Covid-19 and obesity
por: Guglielmi, Valeria, et al.
Publicado: (2022)

Editorial: Peripheral Regulators of Obesity
por: McAinch, Andrew J., et al.
Publicado: (2019)

Editorial: “Linking Hypoxia to Obesity”
por: Foti, Daniela P., et al.
Publicado: (2017)

Editorial: Diabetic renal tubulointerstitial disease
por: Iizuka, Katsumi, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular endocrinology: 2023
por: Santulli, Gaetano
Publicado: (2023)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Editorial: (Osteo)Sarcopenia & sarcopenic obesity
por: Masiero, Stefano, et al.
Publicado: (2023)

The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease
por: Zhang, Yi, et al.
Publicado: (2023)

Editorial: The impact of adipose tissue dysfunction on cardiovascular and renal disease, Volume II
por: Sun, Xiaodong, et al.
Publicado: (2023)

Editorial: Rising stars in cardiovascular endocrinology 2022
por: Lorenzo, Óscar
Publicado: (2023)

Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
por: Wei, Shibo, et al.
Publicado: (2023)

Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
por: Zhang, Chunye, et al.
Publicado: (2021)

Does Family History of Obesity, Cardiovascular, and Metabolic Diseases Influence Onset and Severity of Childhood Obesity?
por: Corica, Domenico, et al.
Publicado: (2018)

Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults
por: Kącka, Anna, et al.
Publicado: (2022)

Editorial: Endocrine and metabolic consequences of childhood obesity
por: Molnár, Dénes, et al.
Publicado: (2022)

Editorial: Leptin, obesity and diet at a glance
por: Hryciw, Deanne H., et al.
Publicado: (2022)

Editorial: A year in review: discussions in obesity
por: Yadegar, Abbas, et al.
Publicado: (2023)

Editorial: Diabetes and aging
por: Barbosa, Helena Cristina de Lima
Publicado: (2022)

Editorial: Technologies for diabetes
por: Salzano, Giuseppina, et al.
Publicado: (2023)

Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
por: Li, Chengshun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1l9snmmfj8ubhnbfetlddpgkro